0 false false false false false false false false false false true false false false false false false No description of principal activity 2023-10-20 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 15224914 2023-10-20 2024-12-31 15224914 2024-12-31 15224914 2023-10-19 15224914 bus:Director1 2023-10-20 2024-12-31 15224914 bus:Director2 2023-10-20 2024-12-31 15224914 core:WithinOneYear 2024-12-31 15224914 core:ShareCapital 2024-12-31 15224914 core:RetainedEarningsAccumulatedLosses 2024-12-31 15224914 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-12-31 15224914 core:CostValuation core:Non-currentFinancialInstruments 2024-12-31 15224914 core:Non-currentFinancialInstruments 2024-12-31 15224914 bus:SmallEntities 2023-10-20 2024-12-31 15224914 bus:AuditExempt-NoAccountantsReport 2023-10-20 2024-12-31 15224914 bus:SmallCompaniesRegimeForAccounts 2023-10-20 2024-12-31 15224914 bus:PrivateLimitedCompanyLtd 2023-10-20 2024-12-31 15224914 bus:AbridgedAccounts 2023-10-20 2024-12-31
COMPANY REGISTRATION NUMBER: 15224914
Axiom BS Holdings Ltd
Filleted Unaudited Abridged Financial Statements
31 December 2024
Axiom BS Holdings Ltd
Abridged Financial Statements
Period from 20 October 2023 to 31 December 2024
Contents
Page
Abridged statement of financial position
1
Notes to the abridged financial statements
3
Axiom BS Holdings Ltd
Abridged Statement of Financial Position
31 December 2024
31 Dec 24
Note
£
Fixed assets
Investments
4
4,229,655
Current assets
Debtors
64,200
Creditors: amounts falling due within one year
4,229,655
------------
Net current liabilities
4,165,455
------------
Total assets less current liabilities
64,200
--------
Capital and reserves
Called up share capital
200
Profit and loss account
64,000
--------
Shareholders funds
64,200
--------
These abridged financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the abridged statement of comprehensive income has not been delivered.
For the period ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its abridged financial statements for the period in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of abridged financial statements .
All of the members have consented to the preparation of the abridged statement of comprehensive income and the abridged statement of financial position for the period ending 31 December 2024 in accordance with Section 444(2A) of the Companies Act 2006.
Axiom BS Holdings Ltd
Abridged Statement of Financial Position (continued)
31 December 2024
These abridged financial statements were approved by the board of directors and authorised for issue on 5 June 2025 , and are signed on behalf of the board by:
Mr L B Gyde
Mr G A Kruk
Director
Director
Company registration number: 15224914
Axiom BS Holdings Ltd
Notes to the Abridged Financial Statements
Period from 20 October 2023 to 31 December 2024
1. General information
The company is a private company limited by shares, registered in England & Wales. The address of the registered office is Midway House, Herrick Way , Staverton Technology Park, Staverton, Cheltenham, Gloucestershire, GL51 6TQ.
2. Statement of compliance
These abridged financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The abridged financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The abridged financial statements are prepared in sterling, which is the functional currency of the entity.
Investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.
Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Investments in associates
Investments in associates accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in associates accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the associate arising before or after the date of acquisition.
Investments in joint ventures
Investments in jointly controlled entities accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in jointly controlled entities accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the joint venture arising before or after the date of acquisition.
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
4. Investments
£
Cost
At 20 October 2023
Additions
4,229,655
------------
At 31 December 2024
4,229,655
------------
Impairment
At 20 October 2023 and 31 December 2024
------------
Carrying amount
At 31 December 2024
4,229,655
------------
5. Directors' advances, credits and guarantees
There are no transactions that require disclosure in the accounts.